Derbyshire Medicines Management and Clinical Policies
GREEN: 1st line for urinary incontinence. Standard/immediate release (IR) preparation is preferred (Decision date - June 2022, June 2023, October 2026)
GREEN: For hyperhidrosis as per Hyperhidrosis guideline for primary care. Standard/immediate release (IR) preparation is preferred (decision date October 2026)
GREY: Modified Release (MR) preparation. The MR preparation should only be used if the IR is unsuitable (i.e. for those who may be at higher risk of sudden deterioration in their physical or mental health). (Decision date - August 2020)
GREY: Oxybutynin patches - for use in patients who are unable to tolerate the oral medication. (Decision date - January 2016)
DNP: Oxybutynin (Velariq 10mg/10ml pre-filled syringe) - for suppression of neurogenic detrusor overactivity in children aged ≥6 years and adults, who are managing bladder emptying by clean intermittent catheterisation, not adequately managed with oral anticholinergics (Decision date - October 2024) Awaiting clinician request
